Stay updated on Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedAdded a site-wide notice about government funding, and updated the revision to v3.4.1; the previous revision v3.4.0 was removed.SummaryDifference0.6%

- Check13 days agoChange DetectedUI changes add a glossary toggle and explain color-coded change highlights (green for additions, red for deletions); the No FEAR Act data item was removed and the revision label updated to v3.4.0.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry v3.3.4 was added to the history, replacing the previous v3.3.3 entry.SummaryDifference0.1%

- Check41 days agoChange DetectedFooter updates include the new 'Revision: v3.3.3' label and removal of the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' notes. These changes are cosmetic and do not affect study data, eligibility, or navigation.SummaryDifference0.2%

- Check77 days agoChange DetectedVersion history now adds an Oversight entry and a Study Status update (2025-11-17) with Revision: v3.3.2, and the prior Revision: v3.2.0 was deleted (2025-07-14).SummaryDifference0.5%

- Check84 days agoChange DetectedRemoval of the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.